Search

everythinglearnresearchcommunity

for

Search:↓

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Trichoscopy is an effective, noninvasive method for early diagnosis of Female Pattern Hair Loss.

New biofabrication technologies could lead to treatments for hair loss.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Trichoscopy is essential for early detection and monitoring of female-pattern hair loss.

Injecting a peptide-hyaluronic acid mix improved hair growth in men with hair loss and was safe.

The document concludes that "hot comb alopecia" is now called "central cicatricial centrifugal alopecia" and its causes are complex.

Trichoscopy of the beard is useful for diagnosing frontal fibrosing alopecia in men.

Both estrogens and androgens are important for health in both males and females.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Congenital triangular alopecia is a hair loss condition present from birth or early childhood with no effective treatment needed.

The stiffness of a wound affects hair growth during healing, with less stiff areas growing more hair.

PRP therapy is effective for hair regrowth and improving hair quality with minimal side effects.

A new mutation in the MBTPS2 gene causes a mild form of IFAP syndrome.

Early diagnosis and quick treatment improve life quality for FFA patients.

Some women with common hair loss may develop permanent hair loss.

A 19-year-old male had two rare skin conditions causing scarring and permanent hair loss.

The man has Temporal Triangular Alopecia, a stable, non-scarring hair loss condition best treated with hair transplantation.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Hair transplants can lead to hair loss from lichen planopilaris, and patients should be tested and wait two years before the procedure.

Treatment with dutasteride, minoxidil, and artificial hair transplantation improved appearance but caused folliculitis.

A rare genetic skin condition usually affecting males was found in a 9-year-old girl.

Dermatoscopy helps diagnose hair and scalp disorders in people with Afro-textured hair, but more research is needed for better understanding and treatment.